BIOSCIENCE HEALTH INNOVATIONS INC. (BHIC)

Every figure this model derived for BHIC, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 712,378 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 1,986,913 AssetsCurrent 2026-06-30
equity 1,834,941 StockholdersEquity 2026-06-30
interest expense 0 InterestPaidNet 2026-06-30
ocf -1,535,122 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 4,491,494 Revenues 2026-06-30
sbc 0 AllocatedShareBasedCompensationExpense 2023-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up BHIC on one particular measure came for.

RatioValue
cash operating margin-13.65
deferred revenue growth-98.97
dilution pct4.55
fcf margin-34.18
growth cv0.66
operating margin-13.65
owner earnings margin-34.18
revenue growth7.77
revenue growth per share3.08
roic-35.03
rule of 40-5.88
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about BHIC's figures. Written by the derivation as it ran, not added afterwards.